Conditions: Multiple Sclerosis
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 464
Healthy volunteers: no

Brief summary:
This study will assess the efficacy, safety, and tolerability of ACT-128800 in patients with relapsing-remitting multiple sclerosis.

Detailed description:

Arms:
arm 1: ACT-128800 Dose 1 arm 2: ACT-128800 Dose 2 arm 3: ACT-128800 Dose 3 arm 4: Matching placebo

Interventions: intervention 1: ACT-128800 Dose 1 intervention 2: Placebo intervention 3: ACT-128800 Dose 2 intervention 4: ACT-128800 Dose 3
Intervention descriptions: intervention 1: ACT-128800 (Dose 1) administered orally once daily intervention 2: Matching placebo administered orally once daily intervention 3: ACT-128800 (Dose 2) administered orally once daily intervention 4: ACT-128800 (Dose 3) administered orally once daily

Protocol document: